Trials / Recruiting
RecruitingNCT06742021
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 195 (estimated)
- Sponsor
- Yunnan Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to address the challenge of predicting the efficacy of targeted and immunotherapy in lung cancer patients. By utilizing two DCE-MRI images-one before treatment and one after one treatment cycle-along with the patients' clinical and pathological information, we aim to achieve accurate prediction of the therapeutic efficacy of targeted and immunotherapy in lung cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Application Value of MRI Imaging in Treatment Decision-Making for Lung Cancer | Chest MRI scans outside of the standard treatment protocol |
Timeline
- Start date
- 2024-11-11
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
- First posted
- 2024-12-19
- Last updated
- 2024-12-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06742021. Inclusion in this directory is not an endorsement.